Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00041964 · ClinicalTrials.gov registry record

A Study of HIV Levels During Pregnancy and After Childbirth

A clinical trial of HIV Infections and Pregnancy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
129
Enrollment target
20
Study locations

NCT00041964 is a study of HIV Infections and Pregnancy that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 129 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00041964, a study of HIV Infections and Pregnancy, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
129 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to find out if HIV-infected pregnant women taking anti-HIV drugs have an increased amount of HIV in their blood (viral load) after having the baby. The purpose of A5153s, a substudy of A5150, is to characterize two anti-HIV drugs (nelfinavir \[NFV\] and lopinavir/ritonavir \[LPV/r\]) in HIV-infected women during pregnancy and after childbirth. Sometimes pregnant women have an increase in their HIV viral load after their baby is born. This study will try to find out how often this happens. It will also examine possible reasons why the increase in viral load occurs.

Conditions Studied

HIV Infections Pregnancy

Study Locations (20)

California

  • Los Angeles County Medical Center/USC - Los Angeles
  • UCLA School of Medicine - Los Angeles
  • UCSD Mother, Child & Adolescent HIV Program - San Diego
  • San Francisco General Hosp - San Francisco

Illinois

  • Northwestern University - Chicago
  • Cook County Hosp Core Ctr - Chicago
  • Rush Presbyterian - Saint Luke's Med Ctr - Chicago
  • Chicago Childrens Memorial Hospital (Pediatric) - Chicago

New York

  • NYU/Bellevue - New York
  • Columbia University - New York
  • State Univ of New York at Stony Brook - Stony Brook

Michigan

  • Hutzel Hospital - Detroit
  • Childrens Hospital of Michigan - Detroit

Alabama

  • Univ of Alabama at Birmingham - Birmingham

Florida

  • Univ of Florida- Health Science Ctr - Jacksonville

Georgia

  • Emory Univ - Atlanta

Hawaii

  • University of Hawaii - Honolulu

Trial Details

FieldValue
Enrollment Target 129 participants

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00041964

The ClinicalTrials.gov registry entry for NCT00041964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (71% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00041964 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT00041964 about?

NCT00041964 is a clinical study titled "A Study of HIV Levels During Pregnancy and After Childbirth". The purpose of this study is to find out if HIV-infected pregnant women taking anti-HIV drugs have an increased amount of HIV in their blood (viral load) after having the baby. The purpose of A5153s, a substudy of A5150, is to characterize two anti-HIV drugs (nelfinavir \[NFV\] and lopinavir/ritona...

What is the current status of trial NCT00041964?

This trial is currently completed. The enrollment target is 129 participants.

What conditions does trial NCT00041964 study?

This clinical trial studies the following conditions: HIV Infections, Pregnancy.

Who is sponsoring clinical trial NCT00041964?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00041964 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Pregnancy

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.